• Behind the science (VSports注册入口)

    'The ever-present threat of contracting a UTI means that my daily routine is ruled by measures to reduce my risk' (VSports app下载)

    LeAnn suffers from chronic urinary tract infections. Here, she describes what it feels like to experience a UTI, the measures she takes to cut down her risk and why she advocates for more personalised care V体育官网. At IDWeek 2025, we'll be discussing the latest advancements in the fight against infectious diseases like UTIs. .

    Read LeAnn's story
    Close video

    V体育官网入口 - Our purpose

    We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2. 5 billion people by the end of the decade, as a successful, growing company where people can thrive VSports手机版. Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. ​.

    Respiratory, immunology and inflammation
    7m
    deaths each year due to lung diseases
    Oncology
    ~10m
    people died from cancer in 2022, making it a leading cause of death worldwide
    HIV
    40m
    people living with HIV globally
    Infectious diseases
    1 in 6
    deaths globally caused by infectious disease

    Behind the science

    V体育安卓版 - Discover how we're getting ahead

    Read our magazine

    Life at GSK

    Find out what it's like to work with us

    man standing and facing the camera

    Make a difference with us

    women walking with a laptop in her hand

    Do your best work with us

    Be yourself

    Be yourself with us

    "V体育官网入口" Positively impacting society and the planet

    Baby laughing

    Access

    We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.

    Scientist inspecting a vial

    Global health and health security (V体育官网入口)

    We are committed to change the trajectory of high burden diseases in lower-income countries with a focus on prevention and treatment of infectious diseases.

    Solar panels with a rainbow in Irvine

    Environment

    We're committed to work towards a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045.

    Scientist in laboratory

    Inclusion

    To be a successful business and deliver positive health impact at scale, we must meet patients’ needs with research that includes those impacted by the disease under study, attract and retain the best talent regardless of background, and support all GSK people to thrive.

    Group of scientists in the lab

    Ethical standards (V体育ios版)

    Our culture guides our people to do the right thing and act on any concerns they have.

    Scientist in conversation

    Product governance

    Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.

    INVESTORS (V体育官网入口)

    We announced our second quarter 2025 results on Wednesday 30 July